Alibaba
BABA
Broadcom
AVGO
Meta Platforms
META
Alphabet-C
GOOG
Alphabet-A
GOOGL
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.